Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Clinical Hospital of Obstetrics and Gynecology "Prof. Dr. Panait Sârbu", 060251 Bucharest, Romania.
Medicina (Kaunas). 2024 Aug 22;60(8):1373. doi: 10.3390/medicina60081373.
: Although considerable research has been devoted to examining the distinctions between fresh and frozen embryo transfer regarding obstetric outcomes and rates of pregnancy success, there is still a scarcity of thorough analyses that specifically examine neonatal outcomes. The objective of our study was to provide an in-depth analysis of neonatal outcomes that occur after the transfer of fresh and frozen embryos (ET vs. FET) in IVF/ICSI cycles. : Multiple databases (PubMed/MEDLINE, Cochrane Library, Web of Science, Wiley, Scopus, Ovid and Science Direct) were searched from January 1980 to February 2024. Two reviewers conducted the article identification and data extraction, meeting inclusion and exclusion criteria. The methodological quality was evaluated using the Newcastle-Ottawa Scale (NOS) or the revised Cochrane Risk of Bias Tool. The meta-analysis was performed using RevMan 5.4. : Twenty studies, including 171,481 participants in total, were subjected to qualitative and quantitative analyses. A significant increase in preterm birth rates was noted with fresh embryo transfer compared to FET in the overall IVF/ICSI population (OR 1.26, 95% CI 1.18-1.35, < 0.00001), as well as greater odds of a low birth weight (OR 1.37, 95% CI 1.27-1.48, < 0.00001) and small-for-gestational-age infants in this group (OR 1.81, 95% CI 1.63-2.00, < 0.00001). In contrast, frozen embryo transfer can result in macrosomic (OR 0.59, 95% CI 0.54-0.65, < 0.00001) or large-for-gestational-age infants (OR 0.64, 95% CI 0.60-0.69, < 0.00001). No significant difference was observed regarding congenital malformations or neonatal death rates. : This systematic review confirmed that singleton babies conceived by frozen embryo transfer are at lower risk of preterm delivery, low birthweight and being small for gestational age than their counterparts conceived by fresh embryo transfer. The data support embryo cryopreservation but suggest that elective freezing should be limited to cases with a proven indication or within the framework of a clinical study.
虽然已经有大量研究致力于探讨新鲜胚胎移植和冷冻胚胎移植在产科结局和妊娠成功率方面的区别,但仍缺乏专门针对新生儿结局的全面分析。我们的研究目的是深入分析体外受精/卵胞浆内单精子注射(IVF/ICSI)周期中新鲜胚胎和冷冻胚胎移植(ET 与 FET)后的新生儿结局。
从 1980 年 1 月到 2024 年 2 月,我们在多个数据库(PubMed/MEDLINE、Cochrane 图书馆、Web of Science、Wiley、Scopus、Ovid 和 Science Direct)中进行了检索。两位评审员对文章进行了识别和数据提取,符合纳入和排除标准。使用纽卡斯尔-渥太华量表(NOS)或修订后的 Cochrane 偏倚风险工具评估方法学质量。使用 RevMan 5.4 进行荟萃分析。
共有 20 项研究,总计 171481 名参与者,进行了定性和定量分析。在整个 IVF/ICSI 人群中,与 FET 相比,新鲜胚胎移植的早产率显著增加(OR 1.26,95%CI 1.18-1.35,<0.00001),低出生体重(OR 1.37,95%CI 1.27-1.48,<0.00001)和小于胎龄儿的风险也更高(OR 1.81,95%CI 1.63-2.00,<0.00001)。相比之下,冷冻胚胎移植可导致巨大儿(OR 0.59,95%CI 0.54-0.65,<0.00001)或大于胎龄儿(OR 0.64,95%CI 0.60-0.69,<0.00001)。在先天性畸形或新生儿死亡率方面没有观察到显著差异。
这项系统评价证实,通过冷冻胚胎移植受孕的单胎婴儿早产、低出生体重和小于胎龄儿的风险低于新鲜胚胎移植受孕的婴儿。这些数据支持胚胎冷冻保存,但表明选择性冷冻应限于有明确适应证的病例,或在临床研究框架内进行。